Ajanta Pharma Limited (NSE:AJANTPHARM)
India · Delayed Price · Currency is INR 3,065.20
-8.40 (-0.27%)
Jun 19, 2026, 3:29 PM IST
Ajanta Pharma Market Cap
Ajanta Pharma has a market cap or net worth of 382.81 billion as of June 18, 2026. Its market cap has increased by 22.08% in one year.
Market Cap
382.81B
Enterprise Value
378.76B
Revenue
54.53B
Ranking
n/a
PE Ratio
36.27
Stock Price
3,065.20
Market Cap Chart
Since April 1, 2002, Ajanta Pharma's market cap has increased from 565.80M to 382.81B, an increase of 67,558.00%. That is a compound annual growth rate of 30.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 19, 2026 | 382.81B | 10.70% |
| Dec 31, 2025 | 345.80B | -5.57% |
| Dec 31, 2024 | 366.20B | 39.58% |
| Dec 29, 2023 | 262.36B | 68.96% |
| Dec 30, 2022 | 155.28B | -19.73% |
| Dec 31, 2021 | 193.46B | 36.89% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aurobindo Pharma | 861.80B |
| Laurus Labs | 762.76B |
| Alkem Laboratories | 642.48B |
| Glenmark Pharmaceuticals | 607.86B |
| Ipca Laboratories | 402.32B |
| Gland Pharma | 362.30B |
| Emcure Pharmaceuticals | 332.39B |
| Wockhardt | 323.23B |